RecruitingNot ApplicableNCT06582121

Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease

Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

457 participants

Start Date

Mar 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and Parkinson\'s disease (SOMPARK)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at sleep problems in people with Parkinson's disease, both in early ("prodromal") stages before a formal diagnosis and in those already diagnosed. Sleep disorders are very common in Parkinson's and may even appear years before movement symptoms. The study aims to understand sleep changes throughout the disease. **You may be eligible if...** - You are 18 or older - You have been diagnosed with Parkinson's disease according to international criteria, with a cognitive score of at least 20/30 on a standard test - Or you are at high risk of developing Parkinson's (e.g., REM sleep behavior disorder or other prodromal markers) **You may NOT be eligible if...** - You have deep brain stimulation (DBS) implanted - You have severe cognitive impairment or dementia - You are taking medications that significantly disrupt sleep in ways that would confound the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPolysomnography

An overnight sleep study


Locations(6)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

CHU de Lille

Lille, France

CHU de Lyon

Lyon, France

CHU de Nantes

Nantes, France

CHU de Nîmes

Nîmes, France

CHU Pitié Salpêtrière

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06582121


Related Trials